01—Abstract
Summary
Summary of the 10-Q filed August 3, 2017. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. reported solid financial results for the second quarter and first six months of 2017, demonstrating growth in net sales and net income attributable to Ecolab compared to the prior year.
Net sales increased by 4% to $3.5 billiona in the second quarter and 3% to $6.6 billion for the first six months. Net income attributable to Ecolab rose by 15% to $296.6 million in the quarter and 12% to $550.1 million for the year-to-date period. The company's performance was bolstered by strength in its Global Industrial and Global Institutional segments, with notable contributions from its Water, Food & Beverage, Paper, and Healthcare businesses.
Despite a decrease in adjusted gross margin due to higher delivered product costs and an unfavorable currency hedge impact, the company's SG&A expenses as a percentage of sales improved. Ecolab also announced new restructuring and cost-saving actions aimed at streamlining operations, which are expected to yield benefits in the latter half of the year.
The company's acquisition of Anios in early 2017 contributed significantly to asset growth and is expected to expand its offerings in the hygiene and disinfection market. Overall, Ecolab demonstrated resilience and growth, managing costs effectively while investing in strategic initiatives.
02—Key points
Key Highlights
- Net sales increased by 4% to $3.5 billion for the second quarter ended June 30, 2017, compared to $3.3 billion in the prior year.
- Net income attributable to Ecolab rose 15% to $296.6 million in the second quarter, or $1.01 per diluted share, up from $0.87 per diluted share in the prior year.
- The Anios acquisition, completed in February 2017 for $798.3 million, is integrated into the Global Institutional segment and is expected to expand Ecolab's healthcare market presence.
- Special charges decreased significantly to $61.2 million in the second quarter of 2017, down from $88.1 million in the same period of 2016, primarily due to the absence of energy-related charges.
- Selling, General, and Administrative (SG&A) expenses as a percentage of sales improved to 32.2% in the second quarter of 2017 from 33.0% in the prior year, indicating improved cost management.
- The company announced restructuring and cost-saving actions in Q2 2017, including a global workforce reduction of approximately 530 positions, expected to result in charges of $40-45 million.
- Ecolab's debt-to-EBITDA ratio improved to 2.6x at June 30, 2017, from 2.8x at the end of 2016, indicating a stronger leverage position.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2017, Ecolab Inc. kept $0.09.
- Revenue$3.46B100.0%
- Cost of revenue−$2.04B58.8%
- Gross profit$1.43B41.2%
- Operating costs−$1.01B29.1%
- Operating income$419.6M12.1%
- Interest, other & tax−$124.8M3.6%
- Net income$294.8M8.5%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2017filed August 3, 2017Financial Statements
Q2 FY2017 against Q2 FY2016
| Line item | Q2 FY2017Q2 FY2016 | Change |
|---|---|---|
| Revenue | $3.46B$3.32B | +4.4% |
| Cost of Revenue | $2.04B$1.79B | +14.1% |
| Gross Profit | $1.43B$1.53B | −6.9% |
| SG&A Expenses | $967.00M$1.09B | −11.6% |
| Operating Income | $419.60M$412.50M | +1.7% |
| Interest Expense | $63.70M$71.50M | −10.9% |
| Net Income | $294.80M$258.40M | +14.1% |
| EPS (Basic) | $1.02$0.88 | +15.9% |
| EPS (Diluted) | $1.00$0.87 | +14.9% |
| Shares Outstanding (Basic) | 289.80M292.40M | −0.9% |
| Shares Outstanding (Diluted) | 294.10M296.50M | −0.8% |
05—Questions
Frequently Asked Questions
What was the primary driver of the sales growth in Q2 2017?
Sales growth in the second quarter of 2017 was primarily driven by solid performance in the Global Industrial and Global Institutional segments. The Water business within Global Industrial and the Specialty and Healthcare businesses within Global Institutional showed particular strength. Pricing and volume increases also contributed positively across several segments.
How did the Anios acquisition impact the financial results?
The acquisition of Anios in February 2017 for approximately $798.3 million contributed to an increase in total assets. It was integrated into the Global Institutional segment and is expected to expand Ecolab's product offerings and geographic footprint in the healthcare market. While the acquisition involved significant consideration and integration costs, it is part of Ecolab's strategy to enhance its position in hygiene and disinfection solutions.
What is the outlook for the Global Energy segment, considering the volatile energy markets?
The Global Energy segment showed a modest increase in fixed currency sales in Q2 2017, driven by strong growth in well stimulation business, partially offset by a decline in the production business. While the segment's results are subject to volatility in oil and gas commodity markets, management remains confident in its long-term growth prospects due to the company's global footprint, broad business portfolio, and strong execution capabilities. Lower oil prices are also expected to benefit other segments through reduced raw material costs.
How is Ecolab managing its debt and financial leverage?
Ecolab reported a decrease in its net debt to EBITDA ratio to 2.6x as of June 30, 2017, down from 2.8x at the end of 2016, indicating improved financial leverage. The company continues to generate strong operating cash flow, which it uses to fund operations, debt repayments, investments, acquisitions, and shareholder returns. Ecolab also has a substantial credit facility to support its liquidity needs.
06—Continue